IRIS Kinetics measures biology directly, with light.

Hundreds of biomarkers. One sample. Minutes. From bench to bedside.

IL-6
75 pg/mL
representative reading
hs-Troponin
30 pg/mL
representative reading
sTNFR-1
14 ng/mL
representative reading
GFAP
220 pg/mL
representative reading

Well researched for 18 years.

In premier journals and institutions.

Institutions and journals in the IRIS publication record, including Boston University, UC San Diego, Massachusetts General Hospital, Nature Communications, Scientific Reports and PLOS ONE.

The same sensor, from the bench to the bedside

On the bench.

Label-free binding kinetics on the MX-200, designed to read up to 100 biomarkers in a run. Coming Q1 2027.

A 25 µL sample.

The volume the TX-100 cartridge is built around. The chip inside it is the same one running in labs today.

At the bedside.

Answers in about ten minutes on the TX-100, which is in development.

This is what our
sensor sees.

Each probe spot brightens as bound material accumulates on it. Traced over time, every spot gives its own binding curve.

Whatever you need to measure.

It finds things other instruments miss.

In one published run, IRIS produced a binding curve that a surface plasmon resonance instrument could not detect at all. Nothing was labeled, tagged or amplified to get there.

What IRIS has measured, with the number of papers for each
What was measuredPapersIn practice
Proteins26list ↗Binding kinetics and concentration, in buffer and in serum.
Viruses and virus particles26list ↗Including a point-of-care monkeypox test, published in 2025 by Unlu group, in partnership with UCSD.
Nucleic acids12list ↗Targeted attomolar microRNA.
Bacteria4list ↗Capture and detection on a microarray of probes.
Extracellular vesicles3list ↗Counted and characterized one vesicle at a time, not as an ensemble.
Single nucleotide polymorphisms3list ↗Allele discrimination on the same chip format.

Two ways in.

Research Use

MX-104 available. MX-200 coming Q1 2027

Multiplexed label-free kinetics, alongside the SPR and BLI systems you already own.

Clinical

The same sensor, aimed at the bedside.

A tabletop platform for critical care, backed by eighteen years of published work.

IRIS MX-series instruments are for research use only. The IRIS TX-100 is in development for clinical use.

Built in Boston.

M. Selim Ünlü, PhD

Founder and CTO

Invented IRIS at Boston University. Fellow of IEEE, AIMBE and Optica.

Farhad Khosravi, PhD

Chief Executive Officer

Ten years scaling biosensor and diagnostic platforms out of the lab.

Charles DeLisi, PhD

Advisor

Former Engineering Dean at Boston University. Presidential Citizens Medal.